Signaling Pathways - HCV NS3-4A protease - G-quadruplexes - gp120-CD4 interaction - Insulin and Insulin-like Receptors
清除全部
- B3705 YYA-021Target: gp120-CD4 interactionSummary: gp120-CD4相互作用抑制剂
- A8440 GSK1838705ATarget: Insulin and Insulin-like Receptors|ALKSummary: ATP竞争性IGF-IR/IR/ALK抑制剂
- A1302 GSK1904529ATarget: Insulin and Insulin-like ReceptorsSummary: IGF-1R/IR 选择性抑制剂
- A1185 BMS-754807Target: Insulin and Insulin-like ReceptorsSummary: 有效的、选择性的IGF-1R和InsR抑制剂
- A3742 Pyridostatin2 CitationTarget: G-quadruplexesSummary: 促生长停滞药物
- A3608 MK 0893Target: Insulin and Insulin-like Receptors|Glucagon ReceptorsSummary: 胰高血糖素受体/ IGF-1R拮抗剂
- A4302 Rosiglitazone maleate中文名: 马来酸罗格列酮Target: Insulin and Insulin-like ReceptorsSummary: PPARγ激动剂,有效的胰岛素敏化剂
- A4031 Telaprevir (VX-950)中文名: 特拉匹韦Target: HCV NS3-4A proteaseSummary: HCV NS3-4A蛋白酶抑制剂